1,721,559 research outputs found
Percutaneous Treatment of Cardiovascular Diseases in Women
Percutaneous Treatment of Cardiovascular Diseases in Wome
Le Nuove frontiere della risonanza magnetica: miocardite, ischemia, malattie valvolari e altro ancora
La rete interospedaliera per il trattamento delle SCA NSTE. Il percorso in emergenza ed in urgenza delle SCA NSTE nella rete interospedaliera
Difficult cases and complications from the catheterization laboratory: a case of mitral cleft
Percutaneous Interventions for Structural Heart Diseas
La variabile XX condiziona la frequenza di trattamento di lesioni complesse, utilizzo di DES e dei risultati a distanza?
Transcatheter Aortic Valve Replacement by trans-subclavian approach
Illustration of TAVR by trans-subclavian approach, in Transcatheter Aortic Valve Replacement (TAVR
Percutaneous Valve Therapy: Choosing the Appropriate Patients and Outcomes
Surgical aortic valve replacement (SAVR) is the current gold standard for the treatment of severe symptomatic aortic stenosis (AS), but transcatheter aortic valve implantation (TAVI) currently represents a viable alternative to conventional SAVR for patients with AS at high risk of operative mortality. On multivariate analysis it has been shown that female gender is independently associated with better recovery of the left ventricular systolic function after TAVI and that left ventricular hypertrophy reverses more frequently in female patients after SAVR. During follow-up, however, women remain significantly more symptomatic compared with men, mainly because they present with more advanced valve disease at a significantly older age
- …
